Trial Details
COMPLETEDBasic Information
| Clinical ID | c4752 |
|---|---|
| Identifier | NCT00004941 |
| Trial Title | Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: monoclonal antibody cA2 |
Participant Information
| Sponsor | FDA Office of Orphan Products Development |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 1996-07 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 1996-07 |